GIANNONE, GAIA
 Distribuzione geografica
Continente #
NA - Nord America 1.732
EU - Europa 1.256
AS - Asia 1.123
OC - Oceania 95
SA - Sud America 34
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.265
Nazione #
US - Stati Uniti d'America 1.562
CN - Cina 691
IT - Italia 323
GB - Regno Unito 271
CA - Canada 151
FR - Francia 137
JP - Giappone 131
DE - Germania 94
AU - Australia 84
ES - Italia 80
IN - India 57
HK - Hong Kong 46
VN - Vietnam 42
NL - Olanda 36
BE - Belgio 35
IE - Irlanda 34
TR - Turchia 30
PL - Polonia 28
KR - Corea 27
DK - Danimarca 26
TW - Taiwan 23
CZ - Repubblica Ceca 22
RU - Federazione Russa 19
CH - Svizzera 18
AT - Austria 17
MX - Messico 17
FI - Finlandia 16
RO - Romania 16
BR - Brasile 15
MK - Macedonia 15
SG - Singapore 14
IL - Israele 13
NO - Norvegia 13
PT - Portogallo 13
SE - Svezia 13
NZ - Nuova Zelanda 11
ZA - Sudafrica 10
IR - Iran 8
TH - Thailandia 8
UA - Ucraina 8
AR - Argentina 7
CL - Cile 5
SA - Arabia Saudita 5
CO - Colombia 4
EG - Egitto 4
ID - Indonesia 4
PH - Filippine 4
AE - Emirati Arabi Uniti 3
BA - Bosnia-Erzegovina 3
GR - Grecia 3
HR - Croazia 3
KW - Kuwait 3
LT - Lituania 3
PE - Perù 3
PK - Pakistan 3
SK - Slovacchia (Repubblica Slovacca) 3
AP - ???statistics.table.value.countryCode.AP??? 2
HU - Ungheria 2
IQ - Iraq 2
IS - Islanda 2
LB - Libano 2
MA - Marocco 2
MO - Macao, regione amministrativa speciale della Cina 2
MY - Malesia 2
NG - Nigeria 2
RS - Serbia 2
UG - Uganda 2
A1 - Anonimo 1
BJ - Benin 1
BT - Bhutan 1
CU - Cuba 1
GE - Georgia 1
MD - Moldavia 1
PR - Porto Rico 1
SY - Repubblica araba siriana 1
TG - Togo 1
Totale 4.265
Città #
Fairfield 138
Houston 108
Ottawa 93
Beijing 92
Ashburn 84
Seattle 79
Shanghai 78
Buffalo 65
Santa Cruz 64
Ann Arbor 61
Chengdu 56
Woodbridge 53
Cambridge 52
Wuhan 46
Wilmington 42
Guangzhou 37
Tokyo 37
Changsha 35
Nanjing 33
London 31
Torino 30
Chicago 29
Dublin 29
Dong Ket 25
Duncan 25
New York 25
Shenyang 22
Los Angeles 18
Nagareyama 18
Rome 17
Central 14
Central District 14
Chongqing 14
Dundee 14
Hangzhou 14
Las Vegas 14
Milan 14
Taipei 14
Warsaw 14
Pisa 13
University Park 13
Vienna 13
Changchun 12
Sydney 12
Helsinki 11
Nottingham 11
Sheffield 11
Bengaluru 10
San Jose 10
Toronto 10
Turin 10
Zhengzhou 10
Boardman 9
Dallas 9
Izmir 9
San Diego 9
Amsterdam 8
Atlanta 8
Berlin 8
Edinburgh 8
Fuzhou 8
Madrid 8
Melbourne 8
Nanchang 8
Seoul 8
Singapore 8
Tonbridge 8
Venezia 8
Ariano nel Polesine 7
Campi Bisenzio 7
Clearwater 7
Columbus 7
Copenhagen 7
Hanoi 7
Hefei 7
Jinan 7
Lexington 7
Mexico 7
Muizenberg 7
Philadelphia 7
Rochester 7
San Francisco 7
Silver Spring 7
Skopje 7
Xian 7
Birmingham 6
Delhi 6
Detroit 6
Grand Forks 6
Guilherand-Granges 6
Lanzhou 6
Manchester 6
Mountain View 6
Phoenix 6
Salt Lake City 6
Taiyuan 6
Argoeuves 5
Arlington 5
Biella 5
Boston 5
Totale 2.131
Nome #
PARP Inhibitors in Ovarian Cancer, file e27ce42f-ad3d-2581-e053-d805fe0acbaa 2.367
Olaparib as maintenance therapy in patients with BRCA 1–2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome, file e27ce42f-f839-2581-e053-d805fe0acbaa 480
Checkpoint inhibitors in endometrial cancer: Preclinical rationale and clinical activity, file e27ce42c-a76a-2581-e053-d805fe0acbaa 244
Are cyclin-dependent kinases 4/6 inhibitors ready for prime time in estrogen-receptor positive metastatic breast cancer?, file e27ce42b-59b1-2581-e053-d805fe0acbaa 217
TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers, file e27ce42d-d5ef-2581-e053-d805fe0acbaa 125
Role of cyclin-dependent kinase inhibitors in endometrial cancer, file e27ce42f-f83c-2581-e053-d805fe0acbaa 124
Endometrial Cancer Stem Cells: Role, Characterization and Therapeutic Implications, file e27ce42e-cec0-2581-e053-d805fe0acbaa 110
Cytoreductive Surgery for Heavily Pre-Treated, Platinum-Resistant Epithelial Ovarian Carcinoma: A Two-Center Retrospective Experience, file e27ce430-2b28-2581-e053-d805fe0acbaa 104
Characteristics and outcome of BRCA mutated epithelial ovarian cancer patients in Italy: A retrospective multicenter study (MITO 21), file e27ce434-d9c6-2581-e053-d805fe0acbaa 97
Reprogramming T-cells for adoptive immunotherapy of ovarian cancer, file e27ce42c-bace-2581-e053-d805fe0acbaa 94
A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience, file e27ce42c-d5e9-2581-e053-d805fe0acbaa 90
Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy, file e27ce430-3de5-2581-e053-d805fe0acbaa 86
Role of Mediterranean diet in preventing platinum based gastrointestinal toxicity in gynecolocological malignancies: A single Institution experience, file e27ce42f-d57f-2581-e053-d805fe0acbaa 72
Is there a role for immunotherapy in ovarian cancer?, file e27ce42f-cca2-2581-e053-d805fe0acbaa 63
Immune checkpoint inhibitors in epithelial ovarian cancer: An overview on efficacy and future perspectives, file e27ce42f-d57e-2581-e053-d805fe0acbaa 63
Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature, file e27ce435-83c1-2581-e053-d805fe0acbaa 13
Veliparib: a new therapeutic option in ovarian cancer?, file e27ce42e-2c92-2581-e053-d805fe0acbaa 8
Biomarkers of central nervous system involvement from epithelial ovarian cancer, file e27ce434-ce4f-2581-e053-d805fe0acbaa 7
Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors, file be64f5a3-0826-412c-9a03-2f74dc5a7cb9 2
Oral etoposide in heavily pre-treated metastatic breast cancer: A retrospective series, file e27ce42c-e4ca-2581-e053-d805fe0acbaa 1
Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature, file e27ce431-e586-2581-e053-d805fe0acbaa 1
Totale 4.368
Categoria #
all - tutte 6.030
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.030


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201950 0 0 0 0 0 0 0 0 0 0 31 19
2019/2020191 13 15 8 23 10 9 13 21 35 9 13 22
2020/20211.238 42 92 144 88 103 124 93 75 90 114 132 141
2021/20221.634 141 144 109 191 171 118 157 126 126 91 153 107
2022/2023934 46 74 142 133 86 54 83 94 106 65 42 9
2023/2024148 6 9 23 13 12 12 26 22 8 17 0 0
Totale 4.368